PG
RGEN icon

PEAK6 Group’s Repligen RGEN Stock Holding History

PEAK6 Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,500
Closed -$1.09M – 4675
2017
Q3 		$1.09M Buy
+28,500
New +$1.19M 0.01% 1894
2016
Q2 		– Sell
-16,400
Closed -$440K – 4675
2016
Q1 		$440K Hold
16,400
– – ﹤0.01% 2399
2015
Q4 		$464K Buy
+16,400
New +$473K ﹤0.01% 2652

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PEAK6 Group's RGEN Position: Q4 2017 in Review

PEAK6 Group sold out of Repligen (RGEN) in Q4 2017, closing a stake of 12,922 shares — an estimated $495K sold.

PEAK6 Group first reported a position in RGEN in Q4 2015 and held it in 2 quarters. The position peaked at $495K in Q3 2017. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2017.

  • PEAK6 Group reported no remaining Repligen position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 12,922 Repligen shares in Q4 2017, an estimated $495K.
  • PEAK6 Group first reported a position in Repligen in Q4 2015 and held it in 2 quarters.
  • PEAK6 Group's Repligen position peaked at $495K in Q3 2017.
  • 184 funds tracked by Wall St. Rank held Repligen as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.